CRT-D device reduces hospital admissions for mild cardiac symptoms

09/1/2009 | Boston Globe (tiered subscription model), The

A combination of defibrillator and a cardiac-resynchronization therapy device proved effective in reducing the chances of patients being hospitalized for less severe forms of cardiac failure, according to a study sponsored by Boston Scientific. By the end of the year, Boston Scientific will ask the FDA to grant "indication expansion" for the CRT-D device, which was already approved for use in those with advanced forms of congestive heart failure, said Fred Colen, president of the company's cardiac rhythm management unit.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ